Professur für Innere Medizin (Nephrologie)

Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial (2022) Bloch M, Kirtane A, Mahfoud F, Azizi M, Basile J, Daemen J, Saxena M, et al. Conference contribution Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) Weil J, Mahfoud F, Schmieder R, Narkiewicz K, Williams B, Fahy M, Mancia G Conference contribution Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry (2022) Schmieder R, Mahfoud F, Mancia G, Narkiewicz K, Ruilope L, Hutton D, Cao K, et al. Journal article HIGH CHOLESTEROL ABSORPTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS: INSIGHTS FROM THE AURORA STUDY (2022) Silbernagel G, Duarte K, Sadiku S, Fauler G, Maerz W, Schmieder R, Jardine AG, et al. Conference contribution Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study (2022) Kolwelter J, Striepe K, Bosch A, Kannenkeril D, Ott C, Schiffer M, Schmieder R Journal article Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial (2022) Weber MA, Schmieder R, Kandzari DE, Townsend RR, Mahfoud F, Tsioufis K, Kario K, et al. Journal article Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial (2022) Weber T, Wassertheurer S, Mayer CC, Hametner B, Danninger K, Townsend RR, Mahfoud F, et al. Journal article LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Conference contribution CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Esler M, Cao K, Lobo M, Sharp ASP, Kandzari DE, Mancia G, Bohm M, et al. Conference contribution IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIES (2022) Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder R Conference contribution